Edgar Filing: VOLITIONRX LTD

Ownership Submission

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0104

Expires:

January 31, 2005

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

Â Skaff Habib

2. Date of Event Requiring Statement (Month/Day/Year)
06/01/2014

3. Issuer Name and Ticker or Trading Symbol
VOLITIONRX LTD [VNRX]

(Last)

(First)

(Middle)

4006 W. SWANN AVENUE

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

__X__ Director	_____ 10% Owner
_____ Officer (give title below)	_____ Other (specify below)

5. If Amendment, Date Original Filed(Month/Day/Year)

(Street)

TAMPA,Â FLÂ 33609

6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	6,286 ⁽¹⁾	D	Â
Common Stock	2,000 ⁽²⁾	D	Â
Common Stock	3,112 ⁽³⁾	D	Â
Common Stock	3,182 ⁽⁴⁾	D	Â

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Warrant	05/11/2012	05/10/2016	Common Stock	3,143 ⁽¹⁾	$ 2.6	D	Â
Option	05/25/2012	05/25/2015	Common Stock	4,000 ⁽⁵⁾	$ 3	D	Â
Option	11/25/2012	11/25/2015	Common Stock	4,000 ⁽⁵⁾	$ 3	D	Â
Option	05/25/2013	05/25/2016	Common Stock	4,000 ⁽⁵⁾	$ 4	D	Â
Option	11/25/2013	11/25/2016	Common Stock	4,000 ⁽⁵⁾	$ 4	D	Â
Option	05/25/2014	05/25/2017	Common Stock	4,000 ⁽⁵⁾	$ 5	D	Â
Option	11/25/2014	11/25/2017	Common Stock	4,000 ⁽⁵⁾	$ 5	D	Â
Option	02/18/2015	02/18/2019	Common Stock	12,500 ⁽⁶⁾	$ 2.5	D	Â
Option	02/18/2016	02/18/2020	Common Stock	12,500 ⁽⁶⁾	$ 3	D	Â

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Skaff Habib 4006 W. SWANN AVENUE TAMPA,Â FLÂ 33609	Â X	Â	Â	Â

Signatures

Habib Skaff		10/03/2014
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	A total of 6,286 Units (1 Unit = 1 common share + 1 warrant to purchase 1/2 a common share) were acquired on May 11, 2012 at a cost basis of $1.75 per Unit, as settlement for certain debts owed to Dr. Habib Skaff by the Company. The warrant is at $2.60 for 4 years.
(2)	On March 25, 2013, Mr. Skaff received 2,000 shares of the Company's common stock with a cost basis of $2.20 per share, as settlement for certain debts owed to Mr. Skaff by the Company.
(3)	On August 16, 2013, Dr. Skaff received 3,112 shares of the Company's common stock with a cost basis of $2.25 per share, as settlement for certain debts owed to Dr. Skaff by the Company.
(4)	On September 24, 2013, Dr. Skaff received 3,182 shares of the Company's common stock with a cost basis of $2.20 per share, as settlement for certain debts owed to Dr. Skaff by the Company.
(5)	A total of 24,000 Options were issued on November 25, 2011 under the Company's 2011 Equity Inventive Plan.
(6)	A total of 25,000 Options were issued on August 18, 2014 under the Company's 2011 Equity Inventive Plan.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.